Ergomed plc provided revenue guidance for the year ended December 31, 2017. For the year, the company’s net service revenues expected to be approximately £39 million, up 35% from £29.2 million in 2016. 2017 total revenues expected to be approximately £47 million, up 21% from £39.2 million in 2016. Service revenue growth of 35% in 2017 was driven by approximately 68% growth in Drug Safety & Medical Information services (DS&MI) which includes PrimeVigilance.